Lv1
40 积分 2025-07-31 加入
Cost-Effectiveness of New Quadruple Therapy Compared With Standard Treatment for Patients With Heart Failure in China
18天前
已完结
The Cost-Effectiveness of Dapagliflozin in Heart Failure with Preserved or Mildly Reduced Ejection Fraction: A European Health-Economic Analysis of the DELIVER Trial
2个月前
已完结
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction
2个月前
已完结
Cost‐effectiveness of dapagliflozin for patients with heart failure across the spectrum of ejection fraction: A pooled analysis of DAPA‐HF and DELIVER data
3个月前
已完结
Cost‐effectiveness of adding dapagliflozin to standard treatment for heart failure with reduced ejection fraction patients in China
3个月前
已完结
Mineralocorticoid receptor antagonists in heart failure: an individual patient level meta-analysis
4个月前
已完结
Mineralocorticoid receptor antagonists with sodium–glucose co-transporter-2 inhibitors in heart failure: a meta-analysis
4个月前
已完结
SGLT2i versus ARNI in heart failure with reduced ejection fraction: a systematic review and meta‐analysis
4个月前
已完结
Sustainability of antimicrobial stewardship programs in secondary hospitals: a cohort study in Southern China
5个月前
已完结
Azilsartan medoxomil: a review of its use in hypertension
8个月前
已完结
皖公网安备34019202002308
